News
-
-
-
-
-
-
-
-
REGULATED PRESS RELEASE
2025 First-half results
-
PRESS RELEASE
Baloise achieves a very healthy profit for the period and makes significant progress with implementing its refocusing strategy
Baloise achieves a very healthy profit for the period and shows significant progress with its refocusing strategy implementation, reporting promising half-year financial results -
PRESS RELEASE
Bioversys reports corporate highlights and key financials for the first half 2025
BioVersys AG reports key financials and corporate highlights for the first half of 2025, including successful Phase 2 outcomes: BV100 Phase 3 on track, Alpibectir Phase 2 with GSK, BV500 collaboration with Shionogi, improved FY 2025 guidance
